Cargando…

Sa1061: CROSS-SECTIONAL AND LONGITUDINAL ASCERTAINMENT OF PATIENTS WITH IBD'S PERCEPTIONS AND EXPERIENCES DURING COVID-19: CLAPPED COVID-19

Detalles Bibliográficos
Autores principales:	Lee, Hanbich, Agawu, Atu, Long, Millie D., Weisbein, Laura, Zhang, Xian, Kappelman, Michael, Bewtra, Meenakshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AGA Institute. Published by Elsevier Inc. 2022
Materias:	AGA Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212330/ http://dx.doi.org/10.1016/S0016-5085(22)60688-7

Ejemplares similares

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

Sa1055: PERCEPTIONS OF ACCESSING CARE AMONG IBD PATIENTS DURING THE COVID-19 PANDEMIC
por: Shaffer, Seth R., et al.
Publicado: (2022)

Fr491 MULTIVARIABLE PREDICTION MODELS FOR HOSPITALIZATION, VENTILATION, AND DEATH FROM COVID-19 IN IBD PATIENTS
por: Sperger, John, et al.
Publicado: (2021)

Sa081 FEAR OF COVID-19 AMONG IBD PATIENTS ACCORDING TO EMPLOYMENT STATUS, EDUCATION AND RESIDENCE AND COMPARED TO OTHER GI CONDITIONS
por: Lo, Bobby, et al.
Publicado: (2021)

Su1482: SCOUT IBD: SURVEILLANCE OF COVID-19 IMPACT ON LONG-TERM OUTCOMES IN IBD
por: Hong, Simon J., et al.
Publicado: (2022)

Sa502 THE FIRST AND SECOND WAVE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TEMPORAL TREND ANALYSIS
por: Kaplan, Gilaad, et al.
Publicado: (2021)

Sa1050: COVID-19 VACCINATION RATES AND POST-VACCINATION INFECTION RISK IN IBD PATIENTS TREATED WITH DISEASE MODIFYING AGENTS: A RESEARCH NETWORK ANALYSIS
por: Chumbe, Julton Tomanguillo, et al.
Publicado: (2022)

Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
por: Hong, Simon J., et al.
Publicado: (2022)

Fr098 IMPACT OF COVID-19 PANDEMIC IN IBD PATIENT CARE
por: Dahiya, Monica, et al.
Publicado: (2021)

Mo1087: MALADAPTIVE BEHAVIORS IN PERSONS WITH IBD DURING THE COVID-19 PANDEMIC
por: Shaffer, Seth R., et al.
Publicado: (2022)

Sa004 DECLINING COLORECTAL CANCER SCREENING IN THE AGE OF COVID-19
por: Torres, Jon Alexander, et al.
Publicado: (2021)

Sa143 THE RISK OF COVID-19 IS HIGHER IN FEMALES USING PROTON PUMP INHIBITORS
por: Ghoneim, Sara, et al.
Publicado: (2021)

Sa1057: OUTCOMES AND MANAGEMENT OF ACUTE NECROTIZING PANCREATITIS DURING THE COVID-19 PANDEMIC
por: Smith, Zachary L., et al.
Publicado: (2022)

Sa1427: THE LONGTERM EFFECTS OF COVID-19 ON ELEVATED LIVER FUNCTION TESTS AND OUTCOMES
por: Shah, Pooja, et al.
Publicado: (2022)

Fr493 DISEASE ACTIVITY IS ASSOCIATED WITH COVID-19 OUTCOMES IN IBD PATIENTS WITH EFFECT MODIFICATION BY AGE
por: Ricciuto, Amanda, et al.
Publicado: (2021)

Fr496 THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Parekh, Rajen, et al.
Publicado: (2021)

Su1496: SARS-COV-2 INFECTION IN IBD: PANDEMIC WAVES AND PREDICTORS OF SEVERE OR PERSISTENT COVID-19
por: Taxonera, Carlos, et al.
Publicado: (2022)

Sa127 AN IBD-RISK VARIANT IN PTPN2 PROMOTES CELLULAR UPTAKE OF SARS-COV-2, WHICH IS MITIGATED BY THE JAK INHIBITOR TOFACITINIB
por: Spalinger, Marianne, et al.
Publicado: (2021)

Sa003 COVID-19 PANDEMIC AND REDUCTION OF COLORECTAL CANCER SCREENING RELATED PROCEDURES IN THE CZECH REPUBLIC
por: Suchanek, Stepan, et al.
Publicado: (2021)

Sa1064: IMPACT OF COVID-19 PANDEMIC ON PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A LOCAL REPORT
por: Tsipotis, Evangelos, et al.
Publicado: (2022)

Sa1049: IMPACT OF THE NOVEL COVID-19 VIRUS ON OUTCOMES OF GASTROINTESTINAL BLEEDING: A MULTICENTER STUDY
por: Chouhan, Vijit, et al.
Publicado: (2022)

Sa1317: HYPERLIPASEMIA IS ASSOCIATED WITH INCREASED MORTALITY IN COVID-19 HOSPITALIZED PATIENTS: A RETROSPECTIVE STUDY
por: Elfert, Khaled, et al.
Publicado: (2022)

Fr498 NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH COVID-19: DATA FROM AN INTERNATIONAL REGISTRY
por: Ungaro, Ryan C., et al.
Publicado: (2021)

Sa126 TROPISM OF SARS-COV-2 FOR BARRETT'S ESOPHAGUS MAY INCREASE SUSCEPTIBILITY TO DEVELOPING COVID-19
por: Jin, Ramon, et al.
Publicado: (2021)

Sa110 IMPACT OF COVID-19 PANDEMIC ON THE MANAGEMENT AND CLINICAL OUTCOMES OF PATIENTS ADMITTED WITH UPPER GASTROINTESTINAL BLEEDING
por: Manomaiwong, Ekawat, et al.
Publicado: (2021)

Sa1053: OUTCOMES OF HOSPITALIZED COVID-19 PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A NATIONAL DATABASE STUDY
por: Melquist, Stephanie J., et al.
Publicado: (2022)

Sa1062: POST-COVID-19 DISORDERS OF GUT-BRAIN INTERACTION (DGBI): AN INTERNET-BASED EPIDEMIOLOGICAL STUDY
por: Bashashati, Mohammad, et al.
Publicado: (2022)

Fr497 INCIDENCE AND OUTCOMES OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Khan, Shahab R., et al.
Publicado: (2021)

Mo1086: MENTAL HEALTH IN IBD DURING THE COVID-19 PANDEMIC: ACCESS TO MENTAL HEALTH CARE AND EXPOSURE TO PANDEMIC NEWS
por: Shaffer, Seth R., et al.
Publicado: (2022)

Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION)
por: Doherty, Jayne, et al.
Publicado: (2022)

Sa114 PREVALENCE OF COVID-19 AMONG OUTPATIENTS PRESENTING FOR NON-URGENT ENDOSCOPY IN A LARGE HEALTHCARE NETWORK
por: Soroudi, Camille, et al.
Publicado: (2021)

Sa1684: DERIVATION OF A RISK SCORE TO PREDICT SEVERE COVID-19 PNEUMONIA IN HOSPITALIZED PATIENTS WITH OVERWEIGHT OR OBESITY
por: Cortés, Pedro, et al.
Publicado: (2022)

Su1485: COVID-19 VACCINE-INDUCED ANTIBODY RESPONSES ARE IMPAIRED IN IBD PATIENTS TREATED WITH INFLIXIMAB, USTEKINUMAB OR TOFACITINIB, BUT NOT THIOPURINES OR VEDOLIZUMAB
por: Alexander, James L., et al.
Publicado: (2022)

Fr509 COVID-19 OUTCOMES AMONG RACIAL AND ETHNIC MINORITY INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASES IN THE UNITED STATES
por: Agrawal, Manasi, et al.
Publicado: (2021)

Sa077 DOES THE LOCKDOWN DUE TO COVID-19 PANDEMIC AFFECT THE LIFESTYLE AND DISEASE ACTIVITY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE?
por: Hosomi, Shuhei, et al.
Publicado: (2021)

Sa1000: DIARRHEA, ELEVATED AST, AND ELEVATION OF INFLAMMATORYRELATED BIOMARKERS IS A PREDICTOR FOR MORTALITY IN MINORITY HOSPITALISED COVID-19 PATIENTS
por: Ashktorab, Hassan, et al.
Publicado: (2022)

Su1492: STRONG HUMORAL IMMUNE RESPONSE TO SARS-COV-2 VACCINE ADDITIONAL DOSE AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES
por: Kappelman, Michael, et al.
Publicado: (2022)

Su1493: COVID-19 RELATED THROMBOTIC, CARDIOVASCULAR, AND RENAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM AN INTERNATIONAL REGISTRY
por: Spiera, Emily, et al.
Publicado: (2022)

Sa012 CORNEAL ABRASIONS DURING ENDOSCOPIC PROCEDURES IN THE COVID-19 ERA ARE A PREVENTABLE PHENOMENON: A QUALITY IMPROVEMENT PROJECT
por: Haghighat, Shida, et al.
Publicado: (2021)

Sa116 A SAFETY ASSESSMENT OF THE RE-OPENING OF AN ACADEMIC MEDICAL CENTER OUTPATIENT ENDOSCOPY UNIT DURING THE COVID-19 PANDEMIC
por: Manski, Scott, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qn02evbt1al7ca5883n9vahg39